OJEM  Vol.5 No.2 , June 2017
Superiority of Prothrombin Complex Concentrate versus Frozen Fresh Plasma in Cardiology Patients with Warfarin Intoxication–Observational Study
Abstract: Objective: The objective of this study was to analyse the reversibility of the anticoagulant effect of warfarin by comparing prothrombin complex concentrate (PCC) versus frozen fresh plasma (FFP) in cardiology patients with serious warfarin intoxication. Methods: This was an observational and retrospective study comprising 67 patients (18 in group I [PCC] and 49 in group II [FFP]). The primary endpoint was the reversal of anticoagulant effect of warfarin after 2 and 24 hours of PCC or FFP administration. Comparisons between the groups were made using T-test and Q-square. Multivariate analyses were conducted using logistic regression, and the results were considered significant when p < 0.05. Complementary analysis was performed using the ROC curve, calculating the area under the curve (AUC), and calculating the cut-off score for the relation between PCC (UI/kg) or FFP (ml/kg) and INR reversibility. Results: The medium dose used was 27.6 UI/kg of PCC and 14.5 ml/kg of FFP. Significant differences were observed between groups I and II in the INR reversibility measurements after 2 hours (33.3% vs. 6.1%, p = 0.001) and 24 hours (38.9% vs. 12.2%, p = 0.009) as well as in the occurrence of pulmonary edema (5.6% vs. 42.9%, OR = 11.10, p = 0.04). The AUC for PCC was 0.891 (CI 95% [0.72 - 1.0]), and for FFP, it was 0.291 (CI 95% [0.09 - 0.49]). Conclusions: PCC is better than FFP treatment in reversing the warfarin intoxication after 2 and 24 hours of administration. Furthermore, PCC showed lower pulmonary edema in cardiology patients.
Cite this paper: de Matos Soeiro, A. , César, M. , Biselli, B. , Bossa, A. , de Carvalho Andreucci Torres Leal, T. , de Almeida Soeiro, M. , Serrano, C. , Hajjar, L. and Oliveira, M. (2017) Superiority of Prothrombin Complex Concentrate versus Frozen Fresh Plasma in Cardiology Patients with Warfarin Intoxication–Observational Study. Open Journal of Emergency Medicine, 5, 75-84. doi: 10.4236/ojem.2017.52007.

[1]   Cabral, K.P., Fraser, G.L., Duprey, J., Gibbons, B.A., Hayes, T., Florman, J.E., et al. (2013) Prothrombin Complex Concentrates to Reverse Warfarin-Induced Coagulopathy in Patients with Intracranial Bleeding. Clinical Neurology and Neurosurgery, 115, 770-774.

[2]   Karaca, M.A., Erbil, B. and Ozmen, M.M. (2014) Use and Effectiveness of Prothrombin Complex Concentrates vs Fresh Frozen Plasma in Gastrointestinal Hemorrhage Due to Warfarin Usage in the ED. The American Journal of Emergency Medicine, 32, 660-664.

[3]   Parry-Jones, A.R., Di Napoli, M., Goldstein, J.N., Schreuder, F.H., Tetri, S., Tatlisumak, T., et al. (2015) Reversal Strategies for Vitamin K Antagonists in Acute Intracerebral Hemorrhage. Annals of Neurology, 78, 54-62.

[4]   Frontera, J.A., Gordon, E., Zach, V., Jovine, M., Uchino, K., Hussain, M.S., et al. (2014) Reversal of Coagulopathy Using Prothrombin Complex Concentrates Is Associated with Improved Outcome Compared to Fresh Frozen Plasma in Warfarin-Associated Intracranial Hemorrhage. Neurocritical Care, 21, 397-406.

[5]   Frontera, J.A., Lewin, J.J., Rabinstein, A.A., Aisiku, I.P., Alexandrov, A.W., Cook, A.M., et al. (2016) Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocritical Care, 24, 6-46.

[6]   Barillari, G., Pasca, S., Barillari, A. and De Angelis, V. (2012) Emergency Reversal of Anticoagulation: From Theory to Real Use of Prothrombin Complex Concentrates. A Retrospective Italian Experience. Blood Transfusion, 10, 87-94.

[7]   Schick, K.S., Fertmann, J.M., Jauch, K.W. and Hoffmann, J.N. (2009) Prothrombin Complex Concentrate in Surgical Patients: Retrospective Evaluation of Vitamin K Antagonist Reversal and Treatment of Severe Bleeding. Critical Care, 13, R191.

[8]   Hanger, H.C., Geddes, J.A., Wilkinson, T.J., Lee, M. and Baker, A.E. (2013) Warfarin-Related Intracerebral Haemorrhage: Better Outcomes When Reversal Includes Prothrombin Complex Concentrates. Internal Medicine Journal, 43, 308-316.

[9]   Fong, W.C., Lo, W.T., Ng, Y.W., Cheung, Y.F., Wong, G.C., Ho, H.F., et al. (2014) The Benefit of prothrombin complex Concentrate in Decreasing Neurological Deterioration in Patients with Warfarin-Associated Intracerebral Haemorrhage. Hong Kong Medical Journal, 20, 486-494.

[10]   Joseph, B., Pandit, V., Khalil, M., Kulvatunyou, N., Aziz, H., Tang, A., et al. (2015) Use of Prothrombin Complex Concentrate as an Adjunct to Fresh Frozen Plasma Shortens Time to Craniotomy in Traumatic Brain Injury Patients. Neurosurgery, 76, 601-607.

[11]   Steiner, T., Poli, S., Griebe, M., Hüsing, J., Hajda, J., Freiberger, A., et al. (2016) Fresh Frozen Plasma versus Prothrombin Complex Concentrate in Patients with Intracranial Haemorrhage Related to Vitamin K Antagonists (INCH): A Randomised Trial. The Lancet Neurology, 15, 566-573.

[12]   Cappabianca, G., Mariscalco, G., Biancari, F., Maselli, D., Papesso, F., Cottini, M., et al. (2016) Safety and Efficacy of Prothrombin Complex Concentrate as First-Line Treatment in Bleeding after Cardiac Surgery. Critical Care, 20, 5.

[13]   Ogawa, S., Szlam, F., Ohnishi, T., Molinaro, R.J., Hosokawa, K., Tanaka. K.A. (2011) A Comparative Study of Prothrombin Complex Concentrates and Fresh-Frozen Plasma for Warfarin Reversal under Static and Flow Conditions. Thrombosis and Haemostasis, 106, 1215-1223.

[14]   Varga, C., Al-Touri, S., Papadoukakis, S., Caplan, S., Kahn, S. and Blostein, M. (2013) The Effectiveness and Safety of Fixed Low-Dose Prothrombin Complex Concentrates in Patients Requiring Urgent Reversal of Warfarin. Transfusion, 53, 1451-1458.

[15]   Guest, J.F., Watson, H.G. and Limaye, S. (2010) Modeling the Cost-Effectiveness of Prothrombin Complex Concentrate Compared with Fresh Frozen Plasma in Emergency Warfarin Reversal in the United Kingdom. Clinical Therapeutics, 32, 2478-2493.